한일화학공사

비상장계속사업자

hanilchem

최영환

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

한일화학공사

Business Reg. No. 1308135264 · CEO 최영환

I.Investment Overview

Target한일화학공사 (1308135264)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명한일화학공사
영문명hanilchem
대표자최영환
사업자등록번호1308135264
법인등록번호1101110415095
설립일1986.01.25
종업원수16명

V.Workforce

16

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW70.5202170.3202267.6202362.7202458.92025
영업이익100M KRW3.620214.920223.620233.42024-12.42025
순이익100M KRW2.120211.620220.920230.12024-15.32025
Item20252024202320222021
자산총계198.5억원181.8억원179.9억원178.5억원176억원
부채총계127.8억원95.8억원94억원93.6억원92.6억원
자본총계70.6억원86억원85.9억원85억원83.4억원
매출액58.9억원62.7억원67.6억원70.3억원70.5억원
영업이익-12.4억원3.4억원3.6억원4.9억원3.6억원
순이익-15.3억원627만원9,462만원1.6억원2.1억원

VII.Financial Ratios

FY2025 basis

-21.05%

영업이익률

-26.04%

순이익률

-7.72%

ROA

-21.7%

ROE

181%

부채비율

35.59%

자기자본비율

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

한일화학공사 투심보고서 | Alpha Lenz